- Home
- SSSS vs CATX Comparison
SSSS vs CATX Comparison
Compare SSSS & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSSS
- CATX
- Stock Information
- Founded
- SSSS 2010
- CATX 1983
- Country
- SSSS United States
- CATX United States
- Employees
- SSSS N/A
- CATX N/A
- Industry
- SSSS Finance: Consumer Services
- CATX Medical/Dental Instruments
- Sector
- SSSS Finance
- CATX Health Care
- Exchange
- SSSS Nasdaq
- CATX Nasdaq
- Market Cap
- SSSS 227.8M
- CATX 239.0M
- IPO Year
- SSSS N/A
- CATX N/A
- Fundamental
- Price
- SSSS $10.11
- CATX $2.22
- Analyst Decision
- SSSS Strong Buy
- CATX Strong Buy
- Analyst Count
- SSSS 4
- CATX 10
- Target Price
- SSSS $10.13
- CATX $12.30
- AVG Volume (30 Days)
- SSSS 255.7K
- CATX 1.8M
- Earning Date
- SSSS 11-04-2025
- CATX 11-10-2025
- Dividend Yield
- SSSS 9.99%
- CATX N/A
- EPS Growth
- SSSS N/A
- CATX N/A
- EPS
- SSSS 2.60
- CATX N/A
- Revenue
- SSSS $2,354,933.00
- CATX $1,235,000.00
- Revenue This Year
- SSSS $7,183.09
- CATX N/A
- Revenue Next Year
- SSSS N/A
- CATX N/A
- P/E Ratio
- SSSS $3.84
- CATX N/A
- Revenue Growth
- SSSS N/A
- CATX N/A
- 52 Week Low
- SSSS $4.21
- CATX $1.60
- 52 Week High
- SSSS $10.34
- CATX $12.82
- Technical
- Relative Strength Index (RSI)
- SSSS 63.88
- CATX 29.41
- Support Level
- SSSS $9.68
- CATX $2.60
- Resistance Level
- SSSS $10.23
- CATX $2.81
- Average True Range (ATR)
- SSSS 0.34
- CATX 0.31
- MACD
- SSSS 0.09
- CATX -0.13
- Stochastic Oscillator
- SSSS 82.45
- CATX 0.88
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.